Pathological Perspectives in Pilocytic Astrocytomas: Extent of resection as the sole critical factor for recurrence-free survival, and the challenge of evaluating conclusions derived from limited data.

Ibrahim Kulac, Irem Yenidogan, Banu Oflaz Sozmen, Arzu Baygul, Soonmee Cha, Melike Pekmezci, Tarik Tihan

Serum neurofilament light chains in progressive multiple sclerosis patients treated with repeated cycles of high-dose intravenous steroids

Lidia Stork, Michael Haupts, Niels Kruse, Petra Spill-Askeridis, Adriane Kutllovci, Martin S. Weber, Wolfgang Brück, Imke Metz

Survey of Neuroanatomic Sampling and Staining Procedures in Alzheimer Disease Research Center Brain Banks

Juan C. Vizcarra, Andrew F. Teich, Brittany N. Dugger, David A. Gutman, and Alzheimer’s Disease Research Center Digital Pathology Working Group


Neurotrauma: 2023 Update

David S. Priemer and Daniel P. Perl

Neurodegeneration: 2023 update

John F Crary

Postmortem changes in brain cell structure: a review

Margaret M. Krassner, Justin Kauffman, Allison Sowa, Katarzyna Cialowicz, Samantha Walsh, Kurt Farrell, John F. Crary, and Andrew T. McKenzie

Neurodevelopmental disorders: 2023 update

Paulina Carriba, Nicola Lorenzón, and Mara Dierssen


From amaurotic idiocy to biochemically defined lipid storage diseases: the first identification of GM1-Gangliosidosis

Burkhard S. Kasper, Christian Thomas, Anne Albers, Ekkehard M. Kasper, and Konrad Sandhoff


My recollections of my 50 years as a neuropathologist from a neurologist's perspective

Yoshio Hashizume

Memoirs of a neuropathologist who was unfit to be a clinician

Hitoshi Takahashi


Vale Emeritus Professor Byron A Kakulas AO, 1932 – 2023

Clive Harper and Colin L Masters


6th Annual Conference of the Neuropathology Society of India (NPSICON) - Meeting Abstracts February 23–25, 2023

Dear reader,

I have exciting news for you: Free Neuropathology has passed the scientific and technical checks by the National Library of Medicine. Accordingly, all FNP papers since our start in 2020 have been indexed by PubMed, and the full text of all future accepted papers will be available via PubMed Central within a few days after publication. Check it out:

Please continue to promote the journal! And if you would like to support us more directly, such as with copyediting, layout, XML programming, organizing a thematic series of papers etc, please let me know at Needless to say that good submissions are always welcome and receive the attention they deserve.

Werner Paulus
Editor, Free Neuropathology

string brainPubmed logo, public domain


Why is the journal called Free Neuropathology and what exactly does free mean?

Free for authors means that there is no article processing fee.
Free for readers means that the journal is published open-access without paywalls or any other restrictions of access. Together, these two features constitute what is called diamond open access. There is no revenue, no financial donation, no commercial advertising and no budget. Any expenses (editorial office, travelling, promotion, software, technical infrastructure etc.) are covered by academic institutions.
Free from publisher means that the journal takes care of all activities that traditionally are carried out by publishers, including but not restricted to copyediting, layout, permanent archiving of papers, maintenance of website, and promotion. This is based on the insight that commercial publishers are primarily interested in profit rather than in science, which has led to an economical and ethical crisis in scientific publishing. We feel that we can perform these activities more efficiently and more passionately than publishers do. For example, we are able to publish papers in the final format within three days after acceptance, including careful copyediting and layout. This is accomplished by our dedicated layout/copyediting board of enthusiastic young colleagues.
Free formatting means that the journal refrains from exuberant formal requirements and extremely detailed instructions for authors, which abound in many scientific journal. However, the journal places much emphasis on a professional and appealing appearance of papers and supports consistent formatting within the paper according to authors’ preferences. Naturally our production software is free software that we can run as we wish, adapt, write tools and redistribute them to others.
Free opinion means that in addition to traditional categories of papers such as original papers, review articles and letters, the journal publishes opinion pieces expressing personal or minority (yet scientifically founded) views, and that it encourages frank scholarly discussion among authors and readers, among the editorial board members, and among scientists and the public. On our website we utilize the open source software called which introduces a sentence-level annotation layer over any paper: comments from anyone about anything and visible for anyone.

If you’d like to make up your own mind about this project, head to the journal’s website at where you’ll find out more about our publication model, our editorial board, FAQ, free access to all papers published so far, and more.

If you wish to unsubscribe from this newsletter, please
send an email to